- Q4 2023 Xeris Biopharma Holdings Inc Earnings Call TranscriptMar 06, 2024$2.52 (-17.78%)Earnings
- Xeris Biopharma Holdings Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Xeris Biopharma Holdings Inc Earnings Call TranscriptNov 09, 2023$1.92Earnings
- Q2 2023 Xeris Biopharma Holdings Inc Earnings Call TranscriptAug 08, 2023$2.55 (+1.23%)Earnings
- Q1 2023 Xeris Biopharma Holdings Inc Earnings Call TranscriptMay 09, 2023$2.65 (+9.76%)Earnings
- Q4 2022 Xeris Biopharma Holdings Inc Earnings Call TranscriptMar 08, 2023$1.37 (-10.47%)Earnings
- Xeris Biopharma Holdings Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 Xeris Biopharma Holdings Inc Earnings Call TranscriptNov 09, 2022$1.54 (-0.76%)Earnings
- Xeris Biopharma Holdings Inc XP-8121 Call TranscriptOct 20, 2022
- Q2 2022 Xeris Biopharma Holdings Inc Earnings Call TranscriptAug 10, 2022$1.92 (+11.66%)Earnings
- Q1 2022 Xeris Biopharma Holdings Inc Earnings Call TranscriptMay 11, 2022$1.64 (-9.77%)Earnings
- Q4 2021 Xeris Biopharma Holdings Inc Earnings Call TranscriptMar 10, 2022$2.67 (+15.77%)Earnings
- Q3 2021 Xeris Biopharma Holdings Inc Earnings Call TranscriptNov 10, 2021$1.99 (+1.02%)Earnings
Q4 2023 Xeris Biopharma Holdings Inc Earnings Call Transcript
Hello, everyone, and welcome to the Xeris Fourth Quarter and Full Year 2023 financial results conference call and webcast. My name is Emily, and I'll be coordinating your call today. (Operator Instructions)
I'll now turn the call over to Allison Wey, Senior Vice President of Investor Relations. Please go ahead.
Thank you, Emily. Good morning and welcome to Xeris Biopharma's Fourth Quarter and Full Year 2023 financial results and conference call. This morning, we issued two press releases, one on the Company's financial results and the other on refinancing. Our debt facilities with paper and capital flows can be found on our website.
We're joined this morning by Paul Edick, Chairman and CEO; and Steve Pieper, our CFO. After our prepared remarks, we will open the lines for questions.
Before we begin, I would like to remind you that this call will contain certain forward-looking statements concerning the Company's future expectations, plans,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)